Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06661291 · ClinicalTrials.gov registry record · NA
Pip Care to Improve Surgical Patient Outcomes
A NA study of Abdominal Surgery, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 1,300
- Enrollment target
- 8
- Study locations
NCT06661291: Recruiting NA study of Abdominal Surgery, sponsored by University of Pittsburgh.
NCT06661291 is a NA study of Abdominal Surgery that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 1,300 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06661291, a NA study of Abdominal Surgery, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,300 participants
- Enrollment target
- 8
- Study locations
Study Summary
Pip Care is developing a personalized, interactive surgical journey platform with a live health coach that works directly with health systems to optimize the perioperative care process. Our Health Insurance Portability and Accountability Act (HIPAA)-compliant platform, Pip, can be integrated into any electronic medical record (EMR), thus alleviating the administrative burden by making operational workflows more efficient. The PIP empowers patients and their families to be more involved in their care by breaking down a patient's healthcare plan into definable, easy-to-understand, and easy-to-complete tasks. Additionally, a health coach completes a health intake to create a personalized perioperative care plan, meets regularly with the patient to encourage goal accomplishment, and facilitates care coordination. This project has 2 phases; Phase I is to assess usability of the Pip Care platform in surgical patients, Phase II is a RCT (Randomized Controlled Trial) to assess surgical clinical outcomes while using Pip compared to standard of care.
Primary Outcome
The total length of hospital stay (# of days) compared between study groups. Outcome will be reported as mean(SD).
Conditions Studied
Interventions
- OTHER Pip Care Digital Health Platform
- OTHER Standard of Care Protocol
Study Locations (8)
Pennsylvania
- UPMC Jameson Hospital - New Castle
- UPMC East Hospital - Pittsburgh
- UPMC Horizon - Pittsburgh
- UPMC Magee Womens Hospital - Pittsburgh
- UPMC Presbyterian Hospital - Pittsburgh
- UPMC St. Margaret - Pittsburgh
- UPMC Shadyside Hospital - Pittsburgh
- UPMC Passavant Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2025-10-13 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
What NCT06661291 shows while recruiting
NCT06661291 is an interventional study that assigns participants to a tested intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 1 condition, with Abdominal Surgery appearing as the primary indexed condition, and to 2 interventions - of which Pip Care Digital Health Platform is the first listed.
NCT06661291 lists 8 locations in 1 state (Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT06661291 about?
NCT06661291 is a clinical study titled "Pip Care to Improve Surgical Patient Outcomes". Pip Care is developing a personalized, interactive surgical journey platform with a live health coach that works directly with health systems to optimize the perioperative care process. Our Health Insurance Portability and Accountability Act (HIPAA)-compliant platform, Pip, can be integrated into an...
What is the current status of trial NCT06661291?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,300 participants. The study started on 2025-10-13. Estimated completion is 2028-09-01.
What conditions does trial NCT06661291 study?
This clinical trial studies the following conditions: Abdominal Surgery.
What interventions are being tested in trial NCT06661291?
The interventions under investigation include: Pip Care Digital Health Platform (OTHER), Standard of Care Protocol (OTHER).
Who is sponsoring clinical trial NCT06661291?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06661291 being conducted?
This trial has 8 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06661291's enrollment target sits among peer trials
1,300 76th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI